Impact Biosystems, Inc.

Impact Biosystems is a health technology company focused on creating innovative biofeedback solutions that enhance physical fitness and overall well-being through data-driven insights. Founded in 2020 in Boston, US, Impact Biosystems, Inc. specializes in developing advanced biofeedback devices for health and wellness. The company raised USD 4.

5 mn in Seed funding on April 9, 2021, co-led by NextView Ventures and Will Ventures, with participation from Union Labs, SOSV, and HAX. The CEO, Bridget Hunter-Jones, has a background in health technology ventures, contributing to the company's mission of improving health outcomes through technology. Impact Biosystems specializes in developing innovative health and wellness solutions, primarily focused on enhancing physical fitness and overall well-being. Their core offerings revolve around advanced biofeedback devices that monitor physiological metrics, facilitating personalized training regimens and health insights for users.

These products cater to a diverse clientele, including fitness enthusiasts, rehabilitation centers, and corporate wellness programs, aiming to enhance performance and recovery through data-driven insights. The company targets multiple geographical markets, including North America and Europe, where there is a growing demand for health technology that empowers consumers. Released in recent years, these products integrate seamlessly into users' daily routines, offering real-time feedback to optimize usage and track progress effectively. Impact Biosystems generates revenue through a direct-to-consumer business model, supported by strategic partnerships with fitness and wellness organizations.

The company offers subscription-based services providing access to premium features, analytics, and personalized coaching based on user data collected through their devices. Customers may purchase flagship products, which include biofeedback devices bundled with a subscription for an app that enhances functionality and user engagement. This transactional structure allows for consistent revenue flow from both one-time device sales and recurring subscription fees, featuring a tiered pricing strategy to cater to a wide range of consumers' needs and budgets. Impact Biosystems, Inc.

plans to utilize the USD 4. 5 mn raised in Seed funding for the development of active recovery technology. The company is designing new products aimed at enhancing user experience and further expanding its market presence. As part of its growth strategy, Impact Biosystems is targeting new geographical regions for expansion, specifically aiming to increase its footprint in Europe by 2023.

With ongoing development projects and a focus on innovation, the company is positioning itself to meet the growing demands of health-conscious consumers.